Skip to main content

Keenova Therapeutics plc

MNKTQDelisted Sep 6, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001567892

Keenova Therapeutics plc was delisted on Sep 6, 2023; its insiders filed their last Form 4 on Jul 23, 2026; 36 institutions reported holding it in 13F filings for Q2 2023, worth $12.4M in total; no superinvestor held it.

13F holders, Q1 2021

Institutional positions in Keenova Therapeutics plc as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
21
No complete 13F data for Q4 2020
Shares held
226.9K
No complete 13F data for Q4 2020
Total value
$84.3K
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting MNKTQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 21 institutions
Q1 2021: 21 institutionsQ2 2021: 11 institutionsQ3 2021: 10 institutionsQ4 2021: 12 institutionsQ1 2022: 10 institutionsQ2 2022: 3 institutionsQ3 2022: 3 institutionsQ4 2022: 47 institutionsQ1 2023: 45 institutionsQ2 2023: 36 institutionsQ3 2023: 4 institutionsQ4 2023: 1 institutionQ1 2024: 1 institutionQ2 2024: 1 institutionQ3 2024: 1 institutionQ4 2024: 1 institutionQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ1 2021: $84.3K
Q1 2021: $84.3KQ2 2021: $64.2KQ3 2021: $4.15KQ4 2021: $8.09KQ1 2022: $8.07KQ2 2022: $1.21MQ3 2022: $889.0KQ4 2022: $80.5MQ1 2023: $75.2MQ2 2023: $12.4MQ3 2023: $12.5KQ4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding MNKTQ and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20251$0
Q3 20251$0
Q2 20251$0
Q1 20251$0
Q4 20241$0
Q3 20241$0
Q2 20241$0
Q1 20241$0
Q4 20231$0
Q3 20234$12.5K
Q2 202336$12.4M
Q1 202345$75.2M
Q4 202247$80.5M
Q3 20223$889.0K
Q2 20223$1.21M
Q1 202210$8.07K
Q4 202112$8.09K
Q3 202110$4.15K
Q2 202111$64.2K
Q1 202121$84.3K

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Keenova Therapeutics plc.

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding MNKTQ in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Gagnon Securities LLC218,300$82.0K0.01%––
Meeder Asset Management Inc3,131$1.00K0.00%––
Valeo Financial Advisors, LLC2,268$1.00K0.00%––
Estabrook Capital Management877$3310.00%––
Huntington National Bank46$00.00%––
Trust Co of Vermont50$00.00%––
AdvisorNet Financial, Inc30$00.00%––
Sonora Investment Management, LLC200$00.00%––
Captrust Financial Advisors33$00.00%––
Highlander Capital Management, LLC1,000$00.00%––
Carroll Financial Associates, Inc.7$00.00%––
Lowe Wealth Advisors, LLC1$00.00%––
IFP Advisors, Inc8$00.00%––
Parallel Advisors, LLC3$00.00%––
Coastal Capital Group, Inc.33$00.00%––
Savior LLC6$00.00%––
Eudaimonia Partners, LLC126$00.00%––
Walled Lake Planning & Wealth Management, LLC15$00.00%––
Hexagon Capital Partners LLC19$00.00%––
Clearview Wealth Advisors LLC28$00.00%––
Freedman Financial Associates, Inc.700$00.00%––